Li Yang, Liu Li, Li Jia, Xie Lin, Wang Guang Ji, Liu Xiao Dong
Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, Jiangsu, PR China.
Eur J Pharmacol. 2009 Aug 15;616(1-3):68-72. doi: 10.1016/j.ejphar.2009.05.026. Epub 2009 Jun 2.
The characteristics of gatifloxacin transport across blood brain barrier were investigated using primary cultured rat brain microvessel endothelial cells (rBMECs) as an in vitro model. Gatifloxacin uptake by rBMECs was time-, temperature- and energy-dependent. Gatifloxacin uptake by rBMECs was not influenced by P-glycoprotein (P-GP) inhibitor cyclosporine A or multidrug resistance associated-proteins (MRPs) inhibitor probenecid. However, verapamil inhibited the uptake in a concentration-dependent manner. Transendothelial transport study showed that transport of gatifloxacin across rBMEC monolayer was bidirectional, verapamil concentration-dependently inhibited transport from the apical to basolateral side, but did not significantly affect transport from basolateral to apical side. Gatifloxacin uptake was decreased in Ca(2+)-deprived medium but increased in Mg(2+)-deprived medium significantly. Furthermore, organic Ca(2+) channel blockers nifedipine and diltiazem had no effect on gatifloxacin uptake, but inorganic Ca(2+) channel blockers Ni(2+) and Mg(2+) inhibited the gatifloxacin uptake. The present study suggests that gatifloxacin transport across rBMECs involves a Na(+)/Ca(2+) exchange mechanism and extracellular Ca(2+) but not P-GP and MRPs.
以原代培养的大鼠脑微血管内皮细胞(rBMECs)作为体外模型,研究了加替沙星透过血脑屏障的特性。rBMECs对加替沙星的摄取具有时间、温度和能量依赖性。rBMECs对加替沙星的摄取不受P-糖蛋白(P-GP)抑制剂环孢素A或多药耐药相关蛋白(MRPs)抑制剂丙磺舒的影响。然而,维拉帕米以浓度依赖性方式抑制摄取。跨内皮转运研究表明,加替沙星跨rBMEC单层的转运是双向的,维拉帕米浓度依赖性地抑制从顶侧向基底侧的转运,但对从基底侧向顶侧的转运没有显著影响。在缺钙培养基中加替沙星摄取减少,但在缺镁培养基中显著增加。此外,有机钙(2+)通道阻滞剂硝苯地平和地尔硫卓对加替沙星摄取没有影响,但无机钙(2+)通道阻滞剂镍(2+)和镁(2+)抑制加替沙星摄取。本研究表明,加替沙星跨rBMECs的转运涉及Na(+)/Ca(2+)交换机制和细胞外钙(2+),而不涉及P-GP和MRPs。